Pan European Consensus Meeting on Stroke Management. Helsingborg, Sweden, 8-10 November, 1995. Geneva Switzerland: World Health Organization Regional Office for Europe.1996.
2.
FeinbergWM, AlbersGW, BarnettI1J.Guidelines for the management of transient ischemic attacks. Stroke.1994; 25: 1320–35.
3.
AdamsHPJr, BrottTG, CrowellRM.Guidelines for the management of patients with acute ischemic stroke. Stroke.1994; 25: 1901–14.
4.
MaybergMR, BatjerHII, DaceyR.Guidelines for the management of aneurysmal subarachnoid hemorrhage. Stroke.1994; 25: 2315–28.
5.
Scottish Intercollegiate Guidelines Network (SIGN).Management of Patients with Stroke: I. Assessment, Investigation, Immediate Management and Secondary Prevention.SIGN, Edinburgh1997.
AlbersGW, EastonJD, SaccoRL, TealP.Antithrombotic and thrombolytic therapy for ischemic stroke. Chest.1998: 114(suppl 5): 683S–698S.
8.
GreshamGE, DuncanPW, StasonW13.Post-Stroke Rehabilitation. Clinical Practice Guideline Number 16. Rockville, Md: US Department of Health and Human Services. Public Health Service. Agency for Health Care Policy and Research. A11CPR Publication 95-0662; 1995.
9.
AdamsHPJr., BrottTG, FurlanAJ.Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. Stroke.1996; 27: 1711–18.
10.
Report of the Quality Standards Subcommittee of the American Academy of Neurology. Practice advisory: thrombolytic therapy for acute ischemic strok-e-summaly statement. Neurology.1996; 47:835–839.
11.
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.Tissue plasminogen activator for acute ischemic stroke. N.EnglJMed.1995; 333: 1581–87.
12.
HackeW, KasteM, FieschiC.Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS 11). Second European-Australasian Acute Stroke Study Investigators. Lancet1998; 352: 1245–51.
13.
RsMacWalterSecondary prevention of stroke. Thromb Haemost, 1999, 82: (Suppl.) 95–103.
14.
KoudstaalP.Secondary prevention following stroke or TIA in patients with nomfieurnatic atrial fibrillation: anticoagulant therapy versus control (Cochrane review). In: The Cochrane Library, Oxford: Update Software. 1999. Updated quarterly.
15.
ChenZM, SandercockPAG, on behalf of the CAST and 1ST Collaborative Groups. Indications for early aspirin use in acute ischaemic stroke: a combined analysis of over 40,000 randomised patients. Stroke1999; 30. 243.
16.
DienerHQ, CunhaL, ForbesC, SiveniusJ, SmetsP, LowenthalA.European Stroke Prevention Study 2: dipyridamole and acetylsalicyclic acid in the secondary prevention of stroke. J Neurol Sci 1996, 143: 1–13.
17.
HankeyGJ, DunbabinDW, SudlowCLM. Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin in the secondary prevention of stroke and other important vascular events among high risk patients (protocol for a Cochrane Review). in: The Cochrane Library.Oxford: Update Software. 1999. Updated quarterly.
18.
HankeyGJ, WarlowCP.Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. Lancet1999; 354: 1457–63.
19.
LichtS.Brief history of stroke and rehabilitation. In LichtS, LichtE (ed) Stroke and its rehabilitiation.Waverly Press, Baltimore. 1975.
20.
ClarkeE.Apoplexy in Hippocratic writings. Bull Hist Med1963; 37: 301.
21.
McHenryLC.Garrison's History of Neurology. Springfield, 1969.
22.
AurelianusC.On acute and chronic diseases. Translated by Drabkin El. Chicago 1950.
23.
ClTissotGymnastique Medicinale et Chirurgicale. Paris 1780.
24.
SchillerC.Concepts of stroke before and after Virchow. Med Hist1970; 14: 115.
25.
WalkerAE.The development of the concept of cerebral localisation in the nineteenth century. Bull HistMed1957; 31: 99.
26.
BrocaPBull Soc Antom, 1861 In McHenry (21).
27.
KabatH.Studies on neuromuscular dysfunction. Xl. New principles of neuromuscular reeducation. Permanente Found Med Bull1947; 5: 3.
28.
FrenkelHS.Die Therapie atactischer Bewegunstbrungen. Mfinchen Med Wcshcr1890; 37: 917.
29.
RankinJ.Cerebral vascular accidents inpatients over the age of 60. II. Prognosis. Scot Med J1957; 2200–215.
30.
PessardE.La reducation motrice dans le service de la clinique Charcot. Thesis, University of Paris1908.
31.
CheyneJ.Cases of apoplexy and lethargy. London 818.
32.
HuntJR.The role of the carotid arteries in the causation of vascular lesions of the brain. Amer J Med Sci1914; 147: 704.
33.
Durand-FardelM.De la contracture dans l'hemorrhage cerebrale. Arch Gen Med1843; 2: 300.
34.
BakerRN.Anticoagulant therapy in cerebral infarct. Neurology1962; 12: 823.
35.
ThompsonJE.Surgery for cerebrovascular insufficiency. Springfield 1967.
36.
Medical Research Council.Streptomycin treatment of pulmonary tuberculosis. BMJ1948; ii:425–29.
37.
YusufS, PetoR, LewisJ, CollinsR, SleightP.Beta blockade during and after myocardial infarction: an overview of the randomised trials. Prog cardiovasc Dis1985; 27: 335–71.
38.
CounsellC, WarlowC, SandercockP, FraserH, Van GijnJ.The Cochrane Collaboration Stroke Review Group: meeting the need for systematic reviews in stroke care. Stroke1995; 26: 498–502.
39.
EdwardsS. (Ed) Neurological physiotherapy - a problem solving approach.Edinburgh, Churchill Livingstone, 1996.
40.
MsRood: Neurophysiological reactions as a basis for physical therapy. Phys Ther Rev, 1954; 34: 444–49.
KabatH, KnottM.Proprioceptive facilitation therapy for paralysis. Physiotherapy1954; 40: 171–76.
43.
BrunstromS.Associated reactions of the upper extremity in adult patients with hemiplegia. An approach to training. Physical Therapy1956; 45: 17–32.
44.
SherringtonC.The integrated action of the nervous system.University Press, New Haven. 1906.
45.
MagnusR.Some results of studies in the physiology of posture. Lancet1926; ii: 531–36.
46.
BobathB.Adult hemiplegia: evaluation and treatment3ed. Heinemann, London, 1990.
47.
Shurnway-CookA, WoollacottM.Motor control, theory and applications, pp 99–115. Williams and Wilkins, Baltimore1995.
48.
CarrJ, SheperdR.A motor relearning programme for stroke.Heinemann, London. 1985.
49.
DaviesPM.Right in the middle.Springer Verlag, Berlin. 1990.
50.
KwakkelG, WagenaarRC, TwiskJW, LankhorstGJ, KoetsierJCIntensity of leg and arm training after primary middle-cerebral-artery stroke: a randomised trial. Lancet1999; 354: 191–96.
51.
WadeD.Rehabilitation after stroke. Lancet1999; 354: 176–77.
52.
JohnstonM, MorrisonV, MacWOterR, PartridgeC.Perceived control, coping and recovery from disability following stroke. Psychology and Health1999; 14, 181–192.
53.
LowJT, PayneS, RoderickP.The impact of stroke on informal carers: a literature review. Soc Sci Med1999; 49: 711–25.
54.
TysonSF, TurnerG.The process of stroke rehabilitation: what happens and why. Clin Rehabil1999; 13: 322–32.
55.
Stroke Unit Trialists’ Collaboration.Collaborative systematic review of randomised trials of organised inpatient (stroke unit) care after stroke. Br Med J1997: 314; 1151–59.
56.
van GijnJ, DennisMS.Issues and answers in stroke care. Lancet1998; 352: (suppl 11) 23–27.
Early Supported Discharge Trialists’. Services for reducing duration of hospital care for acute stroke patients (Cochrane Review). In: The Cochrane Library, Issue 3, 1999. Oxford: Updated quarterly.
59.
MeKnapp: The contribution of Sister Elizabeth Kenny to the treatment of poliomyelitis. Arch Phys Med Rehab, 1955; 36: 510–17.
60.
BrunnstromS: Movement therapy in hemiplegia.New York, Harper & Row, 1970.
BobathB: Adult hemiplegia: Evaluation and treatment (2’ ed.).London, Heinemann, 1978.
63.
FbHorak: Assumption underlying motor control for neurologic rehabilitation. In: ListerMJ (Ed.), Contemporary management of motor control problems: Proceedings of the 11 STEP conference (pp. 11–27). Alexandria VA: Foundation for Physical Therapy, 1991.